Total Nutraceutical (ERGO) 0.3505 $ERGO
Entia Biosciences Inks Major Distribution Agreement for its GROH(R) Brand of Beauty & Wellness Products
ACCESSWIRE - Wed Sep 10, 9:50AM CDT
SHERWOOD, OR / ACCESSWIRE / September 10, 2014 / Entia Biosciences, Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, today announced that it entered into an agreement with Shooting Starzz LLC Distribution Services on September 9th, 2014 to represent the GROH(R) product line in over 24,000 salons in nine states. The GROH(R) Ergo Boost product line leverages powerful antioxidants to promote thicker, stronger hair and lashes, healthier skin, and increased nail strength, as shown in a recent research study.
Entia Biosciences Inks Major Distribution Agreement for its GROH Brand of Beauty & Wellness Products
eTeligis - Wed Sep 10, 9:38AM CDT
SHERWOOD, OR, United States, via ETELIGIS INC., 09/10/2014 - - Entia Biosciences, Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, today announced that it entered into an agreement with Shooting Starzz LLC Distribution Services on September 9th, 2014 to represent the GROH(R) product line in over 24,000 salons in nine states. The GROH(R) Ergo Boost product line leverages powerful antioxidants to promote thicker, stronger hair and lashes, healthier skin, and increased nail strength, as shown in a recent research study.
Entia Biosciences' Supplements Could Prevent Dementia
ACCESSWIRE - Tue Aug 12, 8:55AM CDT
WHITEFISH, MT / ACCESSWIRE / August 12, 2014 / Vitamin D deficiency has been associated with a number of conditions, ranging from cardiovascular disease to certain types of cancers, according to WebMD. On the other side of the coin, research suggests that vitamin D could play a role in the prevention and treatment of diabetes, hypertension, glucose intolerance, multiple sclerosis, and a number of other serious medical conditions.
Entia Biosciences: Beauty From Within
ACCESSWIRE - Tue Jul 22, 9:01AM CDT
Entia Biosciences: Beauty Begins from Within
Entia Biosciences Secures Michael J. Fox Foundation Grant
Marketwire - Mon Jul 14, 9:15AM CDT
Entia Biosciences Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, has been awarded a grant by The Michael J. Fox Foundation for Parkinson's Research to conduct a preclinical study of its ErgoD2(R) medical food formulation as a potential therapy for Parkinson's disease (PD). This study is the second and final in a series of planned studies conducted by Entia utilizing a transgenic murine model developed by Dr. Robert Nussbaum. The first study was successfully conducted in collaboration with Dr. Jack Rogers, PhD, at the Massachusetts General Hospital Neurochemistry Laboratory, in which ErgoD2(R) was shown to increase muscle strength and reduce the toxic buildup of midbrain alpha-synuclein levels. The newly commissioned study has been expanded to measure brain iron levels, key brain biomarkers, as well as, alpha-synuclein levels -- an approach that aims to provide insight into the overall physiologic system of the disease, which may prove invaluable in further substantiating ErgoD2's future role in the treatment and/or prevention of PD.
GROH(R) Exclusive Lifestyle & Wellness Category Sponsor of the International Battle of the Strands Competition
Marketwire - Fri Jul 11, 12:36PM CDT
Entia Biosciences, Inc. (OTCQB: ERGO) is excited to announce that its GROH brand will be an official sponsor of the 4th Annual, Battle of the Strands competition. The Battle of the Strands ("BOTS"
is an International Beauty Competition, reaching 10,000+ professional stylists, trainers & salon owners. Teams compete to be chosen as the top salon with the final competition airing on Discovery Channel in December 2014. The BOTS platform provides GROH with an incredible opportunity to support the industry's brightest stars and educate thousands of professionals on GROH's next generation of skin care and hair care technology.
Entia: An Iron-Clad Opportunity in a Billion Dollar Market
ACCESSWIRE - Wed Apr 02, 10:31AM CDT
WHITEFISH, MT / April 2, 2014 / Iron is an essential trace metal used throughout the human body. For example, iron is an essential component in a protein called hemoglobin that's responsible for carrying oxygen from the lungs to the rest of the body. Iron deficiency is the most common nutritional deficiency and the leading cause of anaemia in the United States, according to the Centers for Disease Control. Conversely, iron overload can be extremely dangerous and cause issues like liver cirrhosis.
GROH(R) Beauty Line Wins Two Readers' Choice Awards
Marketwire - Thu Feb 13, 2:15PM CST
Entia Biosciences, Inc. (OTCQB: ERGO) and its wholly owned subsidiary Total Nutraceutical Solutions (TNS) has been notified that its GROH(R) Ergo Boost All-natural Hair and scalp conditioning treatment has received Readers' Choice awards in both the women's and men's hair care product categories from Beauty Launchpad magazine. The GROH Ergo Boost(R) product line, which addresses hair growth and scalp health with a revolutionary blend of Vitamin D infused argan oil and the powerful natural antioxidant L-Ergothioneine, has been selected best new "Women's Thinning Regimen" and "Men's Thinning Treatment" for 2013.
GROH(R) Reaches Important Milestone With Strategic Partner Mario Tricoci Salon Group
Marketwire - Thu Jan 23, 9:00AM CST
Entia Biosciences, Inc. (OTCQB: ERGO) and its wholly owned subsidiary Total Nutraceutical Solutions (TNS) today announced that the Mario Tricoci Group of salons and day spas, a leading member of the Elizabeth Arden Red Door salon and spa network, will officially launch the entire GROH(R) Ergo Boost product and professional services line on February 1st, 2014. This important milestone and strategic partnership follows an eight month evaluation of the GROH(R) PRO hair and scalp treatment, a deep conditioning back-bar therapy, currently being performed to more than 400 guests per week at Tricoci's seventeen locations. The launch of the full GROH(R) line is further validation of the market interest in the GROH(R) brand and Entia's commercialization strategy for its biotechnology and patent portfolio.
PubNub and Ford AppLink Showcase the Power of the "Internet of Things" with Real-Time Vehicle Dispatch App
PR Newswire - Tue Jan 07, 7:30PM CST
CES - PubNub, the only global Real-Time Network, today announced it is showcasing its winning makeathon integration with the Ford AppLink platform at Ford's booth at CES (North Hall #2222). PubNub was selected as a winner of the VentureBeat and Ford Motor Co. Makeathon for building a real-time dispatch app on PubNub and Ford AppLink. The app provides real-time location tracking and notification via mobile phone to a car's dashboard, bringing Internet of Things communication and technology to cars.
Entia Biosciences' ErgoD2(TM) Could Effectively Treat Parkinson's Disease
ACCESSWIRE - Thu Sep 12, 10:56AM CDT
Entia Biosciences Inc. (OTC Markets: ERGO), a biotechnology company focused on the clinical effects of oxidative stress and free radical reactions in food sciences, has developed a unique compound that combines the power of vitamin D2 with that of ergothioneine. The combination could provide a clinically meaningful response in Parkinson's Disease and a number of other conditions, potentially making the nutritional supplement developer a very lucrative investment.
Entia Biosciences Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th
ACCESSWIRE - Tue Sep 03, 1:35PM CDT
SHERWOOD, OR, September 3, 2013 - (ACCESSWIRE) - Entia Biosciences (OTCQB: ERGO), today announced it will be featured as a presenting company at the 15th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held September 8-10, 2013, at the Millennium Broadway Hotel in New York City.
Entia Biosciences: Unlocking the Full Potential of Ergothioneine
ACCESSWIRE - Thu Aug 29, 9:30AM CDT
Ergothioneine is a naturally occurring amino acid with antioxidant properties. It is commonly found in liver, kidney, black beans, kidney beans and oat bran, as well as bolete and oyster mushrooms. In the late-1920's, human blood testing conducted by researchers (Salt, 1939) showed "normal" ergothioneine levels that were nearly double more recent 2010 results found in a study conducted by Pennsylvania State University (Weigand-Heller, 2012).
Entia Biosciences (ERGO) Cornering the Market on Ergothioneine
ACCESSWIRE - Wed Aug 28, 12:02PM CDT
Ergothioneine is a naturally occurring amino acid with antioxidant properties. It is commonly found in liver, kidney, black beans, kidney beans and oat bran, as well as bolete and oyster mushrooms. In the late-1920's, human blood testing conducted by researchers (Salt, 1939) showed "normal" ergothioneine levels that were nearly double more recent 2010 results found in a study conducted by Pennsylvania State University (Weigand-Heller, 2012).
Entia Biosciences Completes Parkinson's Disease Study
ACCESSWIRE - Mon Aug 26, 10:50AM CDT
SHERWOOD, OR, August 26, 2013 -(ACCESSWIRE)- Entia Biosciences (OTCQB: ERGO), a food science biotechnology company and emerging leader in the field of Nutrigenomics, has completed a Parkinson's disease study in the Neurochemistry Laboratory of Dr. Jack Rogers at Massachusetts General Hospital, Charlestown, MA. The results from the study have been submitted to a peer-reviewed medical journal and the paper is entitled: "Improved Grip Strength and Alpha-Synuclein Levels in a Parkinson's disease Mouse Model Using the Novel Antioxidant Medical Food ErgoD2."
Entia Biosciences Inks Major Distribution Agreement for its GROH(R) Brand of Beauty & Wellness Products
ACCESSWIRE - Wed Sep 10, 9:50AM CDT
SHERWOOD, OR / ACCESSWIRE / September 10, 2014 / Entia Biosciences, Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, today announced that it entered into an agreement with Shooting Starzz LLC Distribution Services on September 9th, 2014 to represent the GROH(R) product line in over 24,000 salons in nine states. The GROH(R) Ergo Boost product line leverages powerful antioxidants to promote thicker, stronger hair and lashes, healthier skin, and increased nail strength, as shown in a recent research study.
Entia Biosciences Inks Major Distribution Agreement for its GROH Brand of Beauty & Wellness Products
eTeligis - Wed Sep 10, 9:38AM CDT
SHERWOOD, OR, United States, via ETELIGIS INC., 09/10/2014 - - Entia Biosciences, Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, today announced that it entered into an agreement with Shooting Starzz LLC Distribution Services on September 9th, 2014 to represent the GROH(R) product line in over 24,000 salons in nine states. The GROH(R) Ergo Boost product line leverages powerful antioxidants to promote thicker, stronger hair and lashes, healthier skin, and increased nail strength, as shown in a recent research study.
Entia Biosciences' Supplements Could Prevent Dementia
ACCESSWIRE - Tue Aug 12, 8:55AM CDT
WHITEFISH, MT / ACCESSWIRE / August 12, 2014 / Vitamin D deficiency has been associated with a number of conditions, ranging from cardiovascular disease to certain types of cancers, according to WebMD. On the other side of the coin, research suggests that vitamin D could play a role in the prevention and treatment of diabetes, hypertension, glucose intolerance, multiple sclerosis, and a number of other serious medical conditions.
Entia Biosciences: Beauty From Within
ACCESSWIRE - Tue Jul 22, 9:01AM CDT
Entia Biosciences: Beauty Begins from Within
Entia Biosciences Secures Michael J. Fox Foundation Grant
Marketwire - Mon Jul 14, 9:15AM CDT
Entia Biosciences Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, has been awarded a grant by The Michael J. Fox Foundation for Parkinson's Research to conduct a preclinical study of its ErgoD2(R) medical food formulation as a potential therapy for Parkinson's disease (PD). This study is the second and final in a series of planned studies conducted by Entia utilizing a transgenic murine model developed by Dr. Robert Nussbaum. The first study was successfully conducted in collaboration with Dr. Jack Rogers, PhD, at the Massachusetts General Hospital Neurochemistry Laboratory, in which ErgoD2(R) was shown to increase muscle strength and reduce the toxic buildup of midbrain alpha-synuclein levels. The newly commissioned study has been expanded to measure brain iron levels, key brain biomarkers, as well as, alpha-synuclein levels -- an approach that aims to provide insight into the overall physiologic system of the disease, which may prove invaluable in further substantiating ErgoD2's future role in the treatment and/or prevention of PD.
GROH(R) Exclusive Lifestyle & Wellness Category Sponsor of the International Battle of the Strands Competition
Marketwire - Fri Jul 11, 12:36PM CDT
Entia Biosciences, Inc. (OTCQB: ERGO) is excited to announce that its GROH brand will be an official sponsor of the 4th Annual, Battle of the Strands competition. The Battle of the Strands ("BOTS"
is an International Beauty Competition, reaching 10,000+ professional stylists, trainers & salon owners. Teams compete to be chosen as the top salon with the final competition airing on Discovery Channel in December 2014. The BOTS platform provides GROH with an incredible opportunity to support the industry's brightest stars and educate thousands of professionals on GROH's next generation of skin care and hair care technology. Entia: An Iron-Clad Opportunity in a Billion Dollar Market
ACCESSWIRE - Wed Apr 02, 10:31AM CDT
WHITEFISH, MT / April 2, 2014 / Iron is an essential trace metal used throughout the human body. For example, iron is an essential component in a protein called hemoglobin that's responsible for carrying oxygen from the lungs to the rest of the body. Iron deficiency is the most common nutritional deficiency and the leading cause of anaemia in the United States, according to the Centers for Disease Control. Conversely, iron overload can be extremely dangerous and cause issues like liver cirrhosis.
GROH(R) Beauty Line Wins Two Readers' Choice Awards
Marketwire - Thu Feb 13, 2:15PM CST
Entia Biosciences, Inc. (OTCQB: ERGO) and its wholly owned subsidiary Total Nutraceutical Solutions (TNS) has been notified that its GROH(R) Ergo Boost All-natural Hair and scalp conditioning treatment has received Readers' Choice awards in both the women's and men's hair care product categories from Beauty Launchpad magazine. The GROH Ergo Boost(R) product line, which addresses hair growth and scalp health with a revolutionary blend of Vitamin D infused argan oil and the powerful natural antioxidant L-Ergothioneine, has been selected best new "Women's Thinning Regimen" and "Men's Thinning Treatment" for 2013.
GROH(R) Reaches Important Milestone With Strategic Partner Mario Tricoci Salon Group
Marketwire - Thu Jan 23, 9:00AM CST
Entia Biosciences, Inc. (OTCQB: ERGO) and its wholly owned subsidiary Total Nutraceutical Solutions (TNS) today announced that the Mario Tricoci Group of salons and day spas, a leading member of the Elizabeth Arden Red Door salon and spa network, will officially launch the entire GROH(R) Ergo Boost product and professional services line on February 1st, 2014. This important milestone and strategic partnership follows an eight month evaluation of the GROH(R) PRO hair and scalp treatment, a deep conditioning back-bar therapy, currently being performed to more than 400 guests per week at Tricoci's seventeen locations. The launch of the full GROH(R) line is further validation of the market interest in the GROH(R) brand and Entia's commercialization strategy for its biotechnology and patent portfolio.
PubNub and Ford AppLink Showcase the Power of the "Internet of Things" with Real-Time Vehicle Dispatch App
PR Newswire - Tue Jan 07, 7:30PM CST
CES - PubNub, the only global Real-Time Network, today announced it is showcasing its winning makeathon integration with the Ford AppLink platform at Ford's booth at CES (North Hall #2222). PubNub was selected as a winner of the VentureBeat and Ford Motor Co. Makeathon for building a real-time dispatch app on PubNub and Ford AppLink. The app provides real-time location tracking and notification via mobile phone to a car's dashboard, bringing Internet of Things communication and technology to cars.
Entia Biosciences' ErgoD2(TM) Could Effectively Treat Parkinson's Disease
ACCESSWIRE - Thu Sep 12, 10:56AM CDT
Entia Biosciences Inc. (OTC Markets: ERGO), a biotechnology company focused on the clinical effects of oxidative stress and free radical reactions in food sciences, has developed a unique compound that combines the power of vitamin D2 with that of ergothioneine. The combination could provide a clinically meaningful response in Parkinson's Disease and a number of other conditions, potentially making the nutritional supplement developer a very lucrative investment.
Entia Biosciences Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th
ACCESSWIRE - Tue Sep 03, 1:35PM CDT
SHERWOOD, OR, September 3, 2013 - (ACCESSWIRE) - Entia Biosciences (OTCQB: ERGO), today announced it will be featured as a presenting company at the 15th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held September 8-10, 2013, at the Millennium Broadway Hotel in New York City.
Entia Biosciences: Unlocking the Full Potential of Ergothioneine
ACCESSWIRE - Thu Aug 29, 9:30AM CDT
Ergothioneine is a naturally occurring amino acid with antioxidant properties. It is commonly found in liver, kidney, black beans, kidney beans and oat bran, as well as bolete and oyster mushrooms. In the late-1920's, human blood testing conducted by researchers (Salt, 1939) showed "normal" ergothioneine levels that were nearly double more recent 2010 results found in a study conducted by Pennsylvania State University (Weigand-Heller, 2012).
Entia Biosciences (ERGO) Cornering the Market on Ergothioneine
ACCESSWIRE - Wed Aug 28, 12:02PM CDT
Ergothioneine is a naturally occurring amino acid with antioxidant properties. It is commonly found in liver, kidney, black beans, kidney beans and oat bran, as well as bolete and oyster mushrooms. In the late-1920's, human blood testing conducted by researchers (Salt, 1939) showed "normal" ergothioneine levels that were nearly double more recent 2010 results found in a study conducted by Pennsylvania State University (Weigand-Heller, 2012).
Entia Biosciences Completes Parkinson's Disease Study
ACCESSWIRE - Mon Aug 26, 10:50AM CDT
SHERWOOD, OR, August 26, 2013 -(ACCESSWIRE)- Entia Biosciences (OTCQB: ERGO), a food science biotechnology company and emerging leader in the field of Nutrigenomics, has completed a Parkinson's disease study in the Neurochemistry Laboratory of Dr. Jack Rogers at Massachusetts General Hospital, Charlestown, MA. The results from the study have been submitted to a peer-reviewed medical journal and the paper is entitled: "Improved Grip Strength and Alpha-Synuclein Levels in a Parkinson's disease Mouse Model Using the Novel Antioxidant Medical Food ErgoD2."
